Wiskott-Aldrich syndrome treatment approved
Positive phase 3 results from insomnia trial
AbbVie announces topline results for phase 3 lymphoma trial
Novo Nordisk Foundation grants $860m to boost innovation in Denmark and Europe
Domain Therapeutics rebrands as Kainova Therapeutics
Mercury Bio launches MB-TIP
Beginnings of breast cancer revealed
Reversal of metabolic dysfunction and liver fibrosis shown
Neuraxpharm enhances ADHD treatment options in Europe
Trenchant BioSystems shows reduction of CGT manufacturing times to 2.5 days
DISCO Pharmaceuticals enters licence agreement with Amgen on cancer
Researchers uncover axonal protein synthesis defect in ALS